GDF-11

GDF-11 is a naturally occurring protein that became famous as the “young blood” molecule — the factor that, in mice sharing blood with younger mice, appeared to rewind an aging heart, muscle and brain. GDF-11 is not FDA-approved and is sold only as a research chemical. The mouse results are hotly disputed, and there is no human proof.

What is GDF-11?

GDF-11 (growth differentiation factor 11, also called BMP-11) is a signaling protein your own body makes — part of the TGF-β superfamily, the same family as myostatin, the protein that limits muscle growth. GDF-11 circulates in the blood and, during development, helps pattern the skeleton and nervous system. It became one of the most-searched longevity compounds after a set of “young blood” experiments suggested GDF-11 might be one of the factors that keeps young tissue young. What people actually buy under the name GDF-11 is a lab-made (recombinant) version of that protein, sold strictly as a research chemical — not a medicine and not a supplement.

How does GDF-11 work?

GDF-11 works like a broadcast message to cells: it latches onto activin type II receptors on the cell surface and flips on the SMAD2/3 signaling pathway inside, changing which genes a cell switches on. Picture it as a thermostat wired into tissue growth and repair — turn the signal up or down and cells behave differently. The catch, and it’s a big one, is that GDF-11 is almost a molecular twin of myostatin (GDF-8), which restrains muscle. They share receptors and downstream wiring, so an effect blamed on GDF-11 can be hard to separate from its cousin. Whether GDF-11 nudges a human toward “younger” tissue, or simply throttles growth like myostatin does, has not been established — and as you’ll see, even the animal data can’t agree.

What does the research show?

The GDF-11 evidence is entirely animal-and-lab evidence, and unusually for a hyped compound, it openly contradicts itself. The headline came from heterochronic parabiosis — surgically joining a young mouse and an old mouse so they share blood. Old hearts got smaller and more youthful, and the group identified GDF-11 as a young-blood factor that declined with age (Loffredo et al., 2013). The same lab then reported GDF-11 rejuvenated aging mouse skeletal muscle (Sinha et al., 2014) and improved the aging mouse brain’s blood vessels and neuron growth (Katsimpardi et al., 2014).

Then the pushback arrived, and it was serious. A separate group reported the near-opposite: that GDF-11 actually rises with age and inhibits muscle regeneration, and — critically — that the antibody and aptamer tools used in the first studies couldn’t cleanly tell GDF-11 apart from myostatin, so the original “GDF-11 declines with age” measurement may have been measuring the wrong thing (Egerman et al., 2015). A third, independent group simply couldn’t reproduce the muscle-rejuvenation effect at all (Hinken et al., 2016). So the honest state of play in mice is a real scientific fight, not a settled win. In people, the picture is emptier still: there is no registered human trial of GDF-11 as a therapy, and the only human data are observational measurements of natural GDF-11 blood levels — muddied by the very same “is this GDF-11 or myostatin?” measurement problem. We grade GDF-11 animal-only, with a mixed verdict and no human data.

What the community reports

Outside the lab, GDF-11 has a small but intense following in anti-aging and biohacker circles, driven almost entirely by the original “young blood” headlines rather than by anyone’s felt results. Because GDF-11 is expensive, hard to source as a genuine active protein, and slow to produce anything a person could notice, first-hand reports are thin and inconsistent. These accounts are anecdotal — no controls, no dosing accuracy, no way to confirm the vial even contained real, active GDF-11. They tell you why people are curious, not whether it works.

Is GDF-11 safe? Side effects

GDF-11’s honest safety answer is “no human data, and the animal data include real red flags.” There is no human safety trial. In animals, GDF-11 is not simply a gentle rejuvenator: several studies report that high or sustained exogenous GDF-11 inhibited muscle regeneration and drove muscle wasting rather than repair (Egerman et al., 2015). That fits its biology — GDF-11 is a close relative of myostatin, the body’s own brake on muscle — so the intuitive idea that “more GDF-11 = younger” may be exactly backwards at the wrong dose. On top of the molecule itself, the practical risk is the product: research-chemical “GDF-11” is unregulated, and a large, fragile signaling protein is easy to mislabel, degrade, or sell inactive, so purity and identity vary wildly from vendor to vendor.

FDA & legal status (2026)

GDF-11 is not FDA-approved and is not a legal dietary supplement. In the United States it is sold strictly as a research chemical — a recombinant protein “for research use only.” No GDF-11 product has a registered human clinical trial as a therapy, and openFDA lists no approved product. Any website marketing GDF-11 as an “anti-aging” or “longevity” treatment is making a commercial claim, not citing an approval. The full dated breakdown is in the FDA & legal status block below.

How is GDF-11 used, and can it be mixed?

GDF-11 is sold as a lyophilized (freeze-dried) recombinant protein that has to be reconstituted with bacteriostatic water before use, and — unlike a small, sturdy peptide — a large signaling protein like this is fussy about handling, so it degrades easily if mishandled. Working out a concentration is still just arithmetic: our reconstitution & dosing calculator turns a vial size, a water volume and a target amount into exact syringe units. People also ask whether GDF-11 can share a syringe with other compounds; our mixing compatibility reference covers what’s commonly combined and where the honest answer is “not enough data” — which, for a protein this understudied, is most of the time.

GDF-11 vs myostatin and follistatin

GDF-11 makes the most sense next to its own family. Myostatin (GDF-8) is GDF-11’s near-twin and the body’s brake on muscle growth, and follistatin is the protein that blocks myostatin to let muscle grow — the opposite lever. Their shared receptors and signaling are exactly why GDF-11’s effects have been so hard to pin down, and why a result credited to GDF-11 can quietly belong to myostatin. If your interest is the broader longevity-peptide space rather than muscle signaling specifically, the mitochondrial compound MOTS-c sits alongside GDF-11 in the longevity cluster.

Frequently asked questions

Does GDF-11 actually reverse aging?

Not provably — and in mice the evidence openly conflicts. One group reported GDF-11 rejuvenated old heart, muscle and brain; other groups found it rises with age, inhibits muscle repair, or has no rejuvenating effect at all. There is no human trial, so “reverses aging” is a hypothesis under active dispute, not a result.

Is GDF-11 the same as myostatin?

No, but they’re close relatives in the same TGF-β family, and that’s the whole problem. GDF-11 and myostatin (GDF-8) share receptors and signaling, and the tools used in early GDF-11 studies struggled to tell them apart — one reason the original “GDF-11 declines with age” claim was challenged.

Is GDF-11 legal?

GDF-11 is sold legally as a research chemical in the United States, but it is not an approved drug or a legal dietary supplement and cannot be sold for human consumption. That’s why every vendor labels it “for research use only.”

Is GDF-11 banned in sport?

Effectively yes. Because GDF-11 has no regulatory approval for human use, it falls under WADA’s S0 “non-approved substances” category and would be prohibited at all times for athletes under anti-doping rules.

Who is GDF-11 for — and who should be cautious?

GDF-11 draws in longevity enthusiasts who read the “young blood reverses aging” headlines and want to know whether a vial can deliver that. The honest framing: GDF-11 is one of the most scientifically interesting stories in the whole aging field — a real circulating protein at the center of an unresolved research fight — and that’s exactly why it’s not something to inject on the strength of a headline. The mouse data contradict each other, some of it points to GDF-11 harming muscle, there is zero human evidence, and the product you’d buy is an unregulated protein that may not even be active. Anyone chasing a proven anti-aging effect should wait for the science to actually converge — right now, it hasn’t.